COVID-19 vaccine

December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
November 23, 2021

VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.

By Bill Snyder
November 15, 2021

Common questions about COVID vaccine and pregnancy

By Nancy Humphrey
Amya Elliott, 9, talks with Bonnie Pilon, RN, prior to receiving her COVID-19 vaccination at Monroe Carell Jr. Children’s Hospital at Vanderbilt. The hospital began mass vaccination for children ages 5-11 on Monday, Nov. 8.
November 11, 2021

Vaccination day at Children’s Hospital

Monroe Carell Jr. Children’s Hospital at Vanderbilt began mass vaccination for children ages 5-11 on Monday, Nov. 8.

By VUMC News and Communications
October 7, 2021

Boosta-Palooza

VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week’s Boosta-Palooza event.

By VUMC News and Communications
September 22, 2021

Rounds: Hard conversations

By Doug Campbell
August 30, 2021

VUMC nurse Shakeya Bean featured in national public service announcement about COVID vaccines

She sees patients who are struggling after a COVID infection. "It doesn't have to be this way," she said.
By Wayne Wood
August 23, 2021

‘DNA’ podcast Season 2 explores COVID, science and trust in communities

By Holly Fletcher
August 10, 2021

Shared antibodies may push COVID-19 variants: VUMC study

Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells.
By Bill Snyder
August 5, 2021

Digital growth, improvements, vaccinations: Leadership Assembly takeaways

Vanderbilt University Medical Center completed its first full fiscal year of the COVID-19 era having achieved remarkable outcomes in digital health, growth and quality because of consistently strong performance from its workforce.
By Holly Fletcher
July 27, 2021

Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.
By Nancy Humphrey
July 26, 2021

Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study

An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.
By Nancy Humphrey
July 19, 2021

Update on COVID-19 for VUMC workforce: what you need to know

COVID-19 is still very much part of our daily lives, and infection rates are on the increase in the community. VUMC continues to effectively manage COVID-19, and outpatient and inpatient volumes are back to pre-COVID levels.
By VUMC News and Communications
1 2 3 4 5